First Capital Advisors Group’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

First Capital Advisors Group’s Portfolio CURE Stock Details CURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$10K	Buy	+100	New	+$9.95K	0.01%	549

Other funds holding CURE

BIM

Bullseye Investment Management Cincinnati, Ohio $164M AUM 8.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

OBWG

Onyx Bridge Wealth Group Tarrytown, New York $930M AUM 16.6% 1-Year Est. Return

First Capital Advisors Group's CURE Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in Direxion Daily Healthcare Bull 3X ETF (CURE) in Q2 2023: 100 shares worth $10K. The stake represents 0.01% of the portfolio and ranks #549 among its holdings.

21 funds tracked by Wall St. Rank hold CURE as of Q2 2023.

First Capital Advisors Group held 100 shares of Direxion Daily Healthcare Bull 3X ETF worth $10K as of Q2 2023.
Direxion Daily Healthcare Bull 3X ETF was a new First Capital Advisors Group position in Q2 2023.
Direxion Daily Healthcare Bull 3X ETF made up 0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #549 holding.
21 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.